Urinalysis Market
Global Urinalysis Market Size to Reach $6.34 Billion by 2030
[London, United Kingdom] – [1st June 2023] – The global urinalysis market size is expected to reach $6.34 billion by 2030, according to a new report by Pharmanucleus. The market is projected to grow at a CAGR of 7.1% from 2023 to 2030.
Urinalysis is a common diagnostic test used to evaluate the health of the urinary system and detect a range of conditions, including infections, kidney diseases, and diabetes. The test is relatively inexpensive and easy to perform, making it a valuable tool for healthcare providers.
The growth of the urinalysis market is being driven by a number of factors, including:
- The aging population: The global population is aging, and older adults are more likely to experience urinary tract infections, kidney diseases, and other conditions that can be detected through urinalysis.
- The increasing prevalence of chronic diseases: Chronic diseases, such as diabetes and kidney disease, are becoming more common, and urinalysis is a valuable tool for monitoring these conditions.
- The development of new technologies: New technologies, such as point-of-care testing and automated urinalysis systems, are making it easier and more convenient to perform urinalysis, which is driving market growth.
The urinalysis market is segmented by product type, application, end user, and region. By product type, the market is segmented into reagent strips, dipsticks, and automated urinalysis systems. Reagent strips are the most common type of urinalysis product, and they are used to test for a variety of substances, including glucose, protein, and leukocytes. Dipsticks are similar to reagent strips, but they are designed to test for a narrower range of substances. Automated urinalysis systems are used to perform more complex urinalysis tests, such as urine sediment analysis.
By application, the market is segmented into clinical and point-of-care testing. Clinical testing is the largest application segment, and it accounts for the majority of the market revenue. Point-of-care testing is a growing application segment, and it is expected to experience significant growth in the coming years.
By end user, the market is segmented into hospitals, clinics, and home healthcare settings. Hospitals are the largest end user segment, and they account for the majority of the market revenue. Clinics are the second-largest end user segment, and they are expected to experience significant growth in the coming years. Home healthcare settings are the smallest end user segment, but they are expected to experience steady growth in the coming years.
The global urinalysis market is dominated by a few major players, including Abbott Laboratories, Roche Diagnostics, Siemens Healthineers, and Beckman Coulter. These companies offer a wide range of urinalysis products, and they have a strong presence in the global market.
The urinalysis market is a dynamic and growing market. The market is being driven by a number of factors, including the aging population, the increasing prevalence of chronic diseases, and the development of new technologies. The market is expected to experience significant growth in the coming years.
For more information about the report and to request a sample copy, please visit
Contact Us:
John.M
Business Consultant
john.m@pharmanucleus.com
Support: +44 (0)20 8470 4967
https://www.pharmanucleus.com/
About Pharmanucleus
Pharma Nucleus is a market research company that provides clients access to custom, syndicated reports and consulting on one platform. As a company with rich knowledge in analysis and research across healthcare domains, such as pharma, medical device and biotechnology. Insights derived from Pharma Nucleus help life sciences and other healthcare organizations accelerate the launch, development, and dissemination of life-saving therapies, navigate significant attention with key opinion leaders, and help ensure equitable access to healthcare services.